Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anish Chemicals is a specialized pharmaceutical manufacturer based in India, primarily focused on the production of high-quality excipients and drug delivery components. The company is a global leader in the manufacturing of neutral pellets, such as sugar spheres and microcrystalline cellulose (MCC) spheres, which are essential for multi-particulate drug delivery systems. Their product portfolio supports the development of sustained-release, controlled-release, and enteric-coated formulations. With a strong emphasis on quality compliance, Anish Chemicals operates WHO-GMP certified facilities and serves a diverse international clientele in the pharmaceutical industry. In addition to standard excipients, they offer customized pelletization and granulation services tailored to specific client requirements. The company's expertise in particle engineering makes them a key partner for pharmaceutical firms developing complex oral dosage forms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anish Chemicals.